These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2954407)

  • 1. [Mathematical study on characteristics of the average steady-state for drugs obeying Michaelis-Menten elimination kinetics].
    Zhou HW
    Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):385-9. PubMed ID: 2954407
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
    Crow JW; Levy G
    Am J Hosp Pharm; 1978 Sep; 35(9):1075-7. PubMed ID: 696752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):209-25. PubMed ID: 671227
    [No Abstract]   [Full Text] [Related]  

  • 5. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A simple method for estimating half-life of drugs obeying Michaelis-Menten elimination kinetics].
    Ding Y; Huang DK; Luo JP
    Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):65-7. PubMed ID: 7771200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A simulation study on the characteristics in a steady-state for Michaelis-Menten elimination kinetics].
    Zhou HW; Jing RR; Qiu ZQ
    Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):483-8. PubMed ID: 2955636
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steady-state characteristics and optimal dosage regimens for Michaelis-Menten elimination drugs].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):61-5. PubMed ID: 7657342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presystemic elimination and biological availability of drugs].
    Klotz U
    Med Lab (Stuttg); 1981; 34(7-8):171-6. PubMed ID: 7311931
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel method of estimating volume of distribution of a drug obeying Michaelis-Menten elimination kinetics.
    Lin YJ; Weidler DJ; Garg DC; Wagner JG
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):197-207. PubMed ID: 671226
    [No Abstract]   [Full Text] [Related]  

  • 11. First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.
    Keller F; Scholle J
    J Pharm Sci; 1981 Feb; 70(2):195-8. PubMed ID: 7205226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fixation of drugs on plasma proteins].
    Tillement JP; Houin G; Zini R; Urien S; Albengres E; Barré J; Sébille B
    Sem Hop; 1983 May; 59(18):1413-22. PubMed ID: 6306828
    [No Abstract]   [Full Text] [Related]  

  • 13. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Michaelis-Menten absorption kinetics in drugs: - examples and implications.
    Wood JH; Thakker KM
    Eur J Clin Pharmacol; 1982; 23(2):183-8. PubMed ID: 7140809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
    Xi NZ
    Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological availability of drugs].
    Holovkin VO
    Farm Zh; 1979; (2):20-5. PubMed ID: 456507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 18. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mathematical analysis concerning the dosage regimen of intravenous infusion of two-compartment model drugs (author's transl)].
    Zhu JB
    Yao Xue Xue Bao; 1980 Dec; 15(12):741-9. PubMed ID: 7257801
    [No Abstract]   [Full Text] [Related]  

  • 20. Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.
    Wu X; Li J; Nekka F
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):151-61. PubMed ID: 25678215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.